Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05962905 · ClinicalTrials.gov registry record
Accuracy Performance Verification of the INVOS™ System in Pediatrics
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 110
- Enrollment target
NCT05962905 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 110 participants.
The verdict
NCT05962905 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
Prospective, observational, multi-center trial designed to capture calibration and performance evaluation data with the INVOS™ system.
Interventions
- OTHER Blood sample
- DEVICE INVOS monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2023-11-16 |
| Est. Completion | 2025-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05962905
The ClinicalTrials.gov registry entry for NCT05962905 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood sample is the first listed.
NCT05962905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05962905 about?
NCT05962905 is a clinical study titled "Accuracy Performance Verification of the INVOS™ System in Pediatrics". Prospective, observational, multi-center trial designed to capture calibration and performance evaluation data with the INVOS™ system.
What is the current status of trial NCT05962905?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2023-11-16. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT05962905?
The interventions under investigation include: Blood sample (OTHER), INVOS monitoring (DEVICE).
Who is sponsoring clinical trial NCT05962905?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.